New molecular markers of early and progressive CJD brain infection
- 11 August 2004
- journal article
- fast track
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 93 (4), 644-652
- https://doi.org/10.1002/jcb.20220
Abstract
Transmissible spongiform encephalopathies (TSEs), including human Creutzfeldt–Jakob disease (CJD), are caused by a related group of infectious agents that can be transmitted to many mammalian species. Because the infectious component of TSE agents has not been identified, we examined myeloid cell linked inflammatory pathways to find if they were activated early in CJD infection. We here identify a specific set of transcripts in CJD infected mouse brains that define early and later stages of progressive disease. Serum amyloid A3 and L-selectin mRNAs were elevated as early as 20 days after intracerebral inoculation. Transcripts of myeloid cell recruitment factors such as MIP-1α, MIP-1β, and MCP1, as well as IL1α and TNFα were upregulated >10 fold between 30 and 40 days, well before prion protein (PrP) abnormalities that begin only after 80 days. At later stages of symptomatic neurodegenerative disease (100–110 days), a selected set of transcripts rose by as much as 100 fold. In contrast, normal brain inoculated controls showed no similar sequential changes. In sum, rapid and simple PCR tests defined progressive stages of CJD brain infection. These markers may also facilitate early diagnosis of CJD in accessible peripheral tissues such as spleen and blood. Because some TSE strains can differentially target particular cell types such as microglia, several of these molecular changes may also distinguish specific agent strains. The many host responses to the CJD agent challenge the assumption that the immune system does not recognize TSE infections because these agents are composed only of the host's own PrP.Keywords
This publication has 40 references indexed in Scilit:
- Toll-Like Receptor 4-Dependent Activation of Dendritic Cells by a RetrovirusJournal of Virology, 2004
- Transmissible Encephalopathies: Speculations and RealitiesViral Immunology, 2003
- Decontamination of Creutzfeldt- Jakob Disease and other transmissible agentsJournal of NeuroVirology, 1997
- Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: Evidence for early up-regulation of the endosomal-lysosomal systemNeuron, 1995
- The Prion DiseasesScientific American, 1995
- The dimensions of Creutzfeldt‐Jakob diseaseTransfusion, 1994
- TRANSMISSION OF CREUTZFELDT-JAKOB DISEASE FROM HUMAN BLOOD AND URINE INTO MICEThe Lancet, 1985
- TRANSMISSION TO ANIMALS OF CREUTZFELDT-JAKOB DISEASE FROM HUMAN BLOODThe Lancet, 1985
- Dextran Sulphate 500 Delays and Prevents Mouse Scrapie by Impairment of Agent Replication in SpleenJournal of General Virology, 1984
- Novel Proteinaceous Infectious Particles Cause ScrapieScience, 1982